Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
28,961,082
-
Total 13F shares
-
1,026,920
-
Share change
-
-123,513
-
Total reported value
-
$1,263,113
-
Price per share
-
$1.23
-
Number of holders
-
16
-
Value change
-
-$169,683
-
Number of buys
-
4
-
Number of sells
-
7
Institutional Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q1 2025
As of 31 Mar 2025,
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,026,920 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., Apollon Financial, LLC, RENAISSANCE TECHNOLOGIES LLC, OneDigital Investment Advisors LLC, TWO SIGMA INVESTMENTS, LP, Sanctuary Advisors, LLC, Lee Financial Co, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, and Alpine Global Management, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.